On Monday, the Washington-based market group AdvaMed released a number of recommendations including trade, taxes, payment, regulatory and research policies that try to preserve med-tech’s placement as an engine of U.S. Economic growth . The agenda also addresses five other issue areas, including the FDA approval process, which AdvaMed had criticized because of its unpredictability; payment plan; trade policy; tax policies, such as the R&D tax credit; and improved support for R&D infrastructure in the U.S .org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent information service, is a scheduled system of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente..Results from both scholarly research are counterintuitive because the enzyme, which is made by the immune system, is supposed to protect cells from HIV and various other viruses, not damage our own genomic DNA. While it’s popular that sunlight and chemical substance carcinogens can mutate DNA, and that mutations are essential for cancer to develop, Harris may be the first to learn that this human being enzyme is a significant cause mutation in cancers. He believes that APOBEC3B is a biological ‘double-edged sword’ that protects some cells from infections such as for example HIV and creates mutations that give rise to cancer in others. Harris hopes to find a method to block APOBEC3B from mutating DNA, just as sunscreen blocks mutations that lead to melanoma.